Table: begin end state 1 17 cytoplasmic 18 39 transmembrane 40 47 non-cytoplasmic 48 69 transmembrane 70 89 cytoplasmic 90 112 transmembrane 113 125 non-cytoplasmic 126 145 transmembrane 146 152 cytoplasmic 153 175 transmembrane 176 194 non-cytoplasmic 195 213 transmembrane 214 232 cytoplasmic 233 254 transmembrane 255 278 non-cytoplasmic 279 310 transmembrane 311 330 cytoplasmic 331 351 transmembrane 352 356 non-cytoplasmic 357 375 transmembrane 376 386 cytoplasmic 387 406 transmembrane 407 411 non-cytoplasmic 412 429 transmembrane 430 443 cytoplasmic
Input: >PP_2802 FitnessBrowser__Putida:PP_2802 MSQSTSGASLRRSLGPFSVLLFGLAFLAPLIVFGTYGVITQASGNTTAMAYLVAATGVVF TALSYGRLVRVFPVAGSAYTYTRKMLNANLGFMVGWAALLDYFFIPMLIWLLGASYLNMA FPEVPQWVWITGFIVSTSLLNVLGIQVANRFNVLLMVVQLVIIAVFIGLCVHYIVAANGP GGLLSAKPFFNQDVPFATSMAGAAIAAYSFLGFDALSTLSEETRDPGRTLPRAILLVALI GGSVYVGSSYFMYLAHPSPTFELVDGAAFEIARMIGGDLFFAVVLTGIIVAHFAAGMSFQ ASVGRLLYALGRDNQLPRRLFGALHPRYKTPAFNILLCGVFGTAGFGLTIATATSLVNFG AFLAFTAVNLCALRLTFDARVKDGAGLLRGVLFPLIGLVTAGWMLVSLDKDALIMGGCWL GLGLVYLACRTSLFRNPVPDALV
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server